Technology-Enabled Remote Hypertension Management To Advance Health Equity
NCT ID: NCT06331754
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
1500 participants
INTERVENTIONAL
2024-03-18
2026-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Hypertension Management for Black Patients
NCT06527794
Remote Monitoring and Social Support for Hypertension Management
NCT03416283
Technology-enabled Management Versus Usual Care for Blood Pressure
NCT05479461
Machine Learning to Reduce Hypertension Treatment Clinical Inertia
NCT05406336
Team Based Equity Conscious Telemedicine Approach to Hypertension
NCT06424730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Technology-enabled blood pressure management
The intervention will consist of a technology-enabled remote hypertension management program. Participants will be given a cellular blood pressure (BP) cuff and patients with heart failure and chronic kidney disease stage 3b-5 will be given a scale also. Patients will undergo a series of protocolized software-driven medication initiation and titration steps until they reach a blood pressure target of systolic blood pressure \< 130 mmHg and diastolic blood pressure \< 80 mmHg. Patients will be subsequently monitored for up to 12 more months. If their blood pressure increases, they can re-enter active management.
Technology-enabled blood pressure management
The intervention will consist of a technology-enabled remote hypertension management program.
No intervention
Patients meeting inclusion care undergoing usual care in control clinics.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technology-enabled blood pressure management
The intervention will consist of a technology-enabled remote hypertension management program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* uncontrolled hypertension: as defined as SBP \> 140 or DBP \> 90 on 2 successive clinic visits
Exclusion Criteria
* visually impaired
* cognitively impaired
* hospice care
* on hemodialysis at enrollment
* New York Heart Association Class IV heart failure
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atman Health, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATMANHEALTH001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.